Status:

UNKNOWN

Existence in the Human Digestive Flora of Phages Able to Prevent the Acquisition of Multiresistant Enterobacteria

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Multiresistant Enterobacteriaceae

Eligibility:

All Genders

18+ years

Brief Summary

This research focuses on antibiotic resistant bacteria that may reside in the digestive tract (intestinal flora) of everyone. When we develop an infection, the bacteria in question is, often, already...

Detailed Description

Evaluate the association between the presence of phage (s) in patients not carrying E. coli or K. pneumoniae ESBL or carbapenemase (EPC) (Ec-ESBL / EPC or Kp-ESBL / EPC) and subsequent acquisition Of ...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years old
  • Admission in reanimation
  • Duration of stay \> 72 h.

Exclusion

  • Absence of at least 2 consecutive faeces.

Key Trial Info

Start Date :

February 12 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 1 2020

Estimated Enrollment :

460 Patients enrolled

Trial Details

Trial ID

NCT03231267

Start Date

February 12 2018

End Date

February 1 2020

Last Update

July 16 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

réanimation médicale Hôpital Saint Antoine

Paris, France, 75012